About the Pleuropulmonary Blastoma Session
Pleuropulmonary blastoma (PPB) is a rare and aggressive pediatric lung cancer originating in the tissues of the lungs and pleura. Cancer research has significantly advanced our understanding of PPB, particularly its genetic underpinnings. Mutations in the DICER1 gene are strongly associated with PPB, providing a genetic marker for early diagnosis and familial screening. Current research is focused on understanding the molecular pathways influenced by DICER1 to develop targeted therapies. Innovative treatment strategies, including personalized medicine and immunotherapy, are being explored to improve outcomes. Despite its rarity, PPB research is pivotal in enhancing survival rates and quality of life for affected children, underscoring the importance of ongoing genetic and therapeutic studies.
Topics Covered in Pleuropulmonary Blastoma
DICER1 Syndrome
Cystic & Solid Subtypes
Lung Cyst Surveillance
Pediatric Lung Tumors
Surgical Resection
Multiagent Chemotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Pleuropulmonary Blastoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Pleuropulmonary Blastoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Pleuropulmonary Blastoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Pleuropulmonary Blastoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pleuropulmonary Blastoma Conference 2027 — FAQs
What is the Pleuropulmonary Blastoma track at CIOC 2027?
The Pleuropulmonary Blastoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Pleuropulmonary Blastoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pleuropulmonary Blastoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Pleuropulmonary Blastoma are all welcome — whether presenting or attending.
Can I present my research in the Pleuropulmonary Blastoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Pleuropulmonary Blastoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Pleuropulmonary Blastoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.